Ali Kadhim, Y., Umer Khan, M
Exclusion criteria for both cohorts included a type 1 diabetes (T1D) diagnosis, gestational diabetes, metastatic cancer, comorbid conditions related to unintentional weight change, bariatric surgery, pregnancy, and pharmacy claims for anti-obesity medication in the baseline or follow-up periods
We have a lot of inquiries from angel investors to take [the company] national, but we want to control the money that comes in to fund the research, he said
How is Retatrutide different from single GLP-1 compounds
Saxenda is a prescription medicine that helps with weight loss
Understanding your genetic peptide profile allows PlexusDx providers to tailor your semaglutide dose and treatment strategy with greater precision